Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors

Haematologica. 2024 Nov 28. doi: 10.3324/haematol.2024.286867. Online ahead of print.

Authors

Fnu Aperna¹, Ali K Alsugair¹, Saubia Fathima¹, Ayalew Tefferi¹, Naseema Gangat²

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN.
² Division of Hematology, Mayo Clinic, Rochester, MN. [email protected].

PMID: 39605215
DOI: 10.3324/haematol.2024.286867

Abstract

Not available.